YD Bio Statistics
Total Valuation
YD Bio has a market cap or net worth of $1.13 billion. The enterprise value is $1.12 billion.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
YD Bio has 70.32 million shares outstanding. The number of shares has increased by 4.01% in one year.
Current Share Class | 70.32M |
Shares Outstanding | 70.32M |
Shares Change (YoY) | +4.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.46% |
Owned by Institutions (%) | n/a |
Float | 69.30M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 34.30 |
Forward PS | n/a |
PB Ratio | 3.50 |
P/TBV Ratio | 287.74 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2,198.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.18, with a Debt / Equity ratio of 0.00.
Current Ratio | 13.18 |
Quick Ratio | 12.91 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,893.69 |
Financial Efficiency
Return on equity (ROE) is -42.69% and return on invested capital (ROIC) is -27.34%.
Return on Equity (ROE) | -42.69% |
Return on Assets (ROA) | -25.43% |
Return on Invested Capital (ROIC) | -27.34% |
Return on Capital Employed (ROCE) | -22.15% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.14 |
Inventory Turnover | 6.65 |
Taxes
In the past 12 months, YD Bio has paid $25,080 in taxes.
Income Tax | 25,080 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.04 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 50.23 |
Average Volume (20 Days) | 186,394 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, YD Bio had revenue of $510,360 and -$1.41 million in losses. Loss per share was -$1.29.
Revenue | 510,360 |
Gross Profit | 155,356 |
Operating Income | -1.46M |
Pretax Income | -1.39M |
Net Income | -1.41M |
EBITDA | -1.36M |
EBIT | -1.46M |
Loss Per Share | -$1.29 |
Full Income Statement Balance Sheet
The company has $3.13 million in cash and $22,265 in debt, giving a net cash position of $3.11 million or $0.04 per share.
Cash & Cash Equivalents | 3.13M |
Total Debt | 22,265 |
Net Cash | 3.11M |
Net Cash Per Share | $0.04 |
Equity (Book Value) | 6.59M |
Book Value Per Share | 4.57 |
Working Capital | 3.20M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$1.84 million and capital expenditures -$74,914, giving a free cash flow of -$1.91 million.
Operating Cash Flow | -1.84M |
Capital Expenditures | -74,914 |
Free Cash Flow | -1.91M |
FCF Per Share | -$0.03 |
Full Cash Flow Statement Margins
Gross margin is 30.44%, with operating and profit margins of -286.45% and -276.58%.
Gross Margin | 30.44% |
Operating Margin | -286.45% |
Pretax Margin | -271.67% |
Profit Margin | -276.58% |
EBITDA Margin | -265.93% |
EBIT Margin | -286.45% |
FCF Margin | n/a |
Dividends & Yields
YD Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.01% |
Shareholder Yield | -4.01% |
Earnings Yield | -0.13% |
FCF Yield | -0.17% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
YD Bio has an Altman Z-Score of 104.61 and a Piotroski F-Score of 1.
Altman Z-Score | 104.61 |
Piotroski F-Score | 1 |